Evolution, Medicine, and Public Health - An evolutionary medicine perspective on the design of non-hormonal contraceptives for women

Sep 23, 2026

Uploaded by McGucket

Evolutionary mismatches between women’s reproductive life histories in industrialized societies and those of Paleolithic ancestors drive risk for gynecological pathologies and breast cancer. Earlier menarche, delayed first full-term pregnancy, and reduced or absent lactation are highlighted. Hormonal contraceptives can lower ovarian and endometrial cancer risks, but next-generation non-hormonal designs should preserve these non-contraceptive benefits while potentially reducing breast cancer risk. The framework also informs male contraception by balancing endocrine homeostasis with effective fertility control.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages8

Reading Time20 min

AccessFree to download

Abstract

Introduction

Evolutionary mismatches and reproductive patterns

Cancer risks and contraceptive effects

Lay Summary

Keywords

1 Evolution, Medicine, and Public Health [2026] pp.1---8 [https://doi.org/10.1093/emph/eoag008](https://doi.org/10.1093/emph/eoag008) Advance access date 29 April 2026 COMMENTARY An evolutionary medicine perspective on the design of non-hormonal contraceptives for women Ned J. Place 1 , * and Wei Yan 2 1 Department of Population Medicine & Diagnostic Sciences, College of Veterinary Medicine, Cornell University, S1-088 Schurman Hall, 240 Farrier Rd., Ithaca, NY 14853, USA; and 2 School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, 1770 NE Stadium Way, Pullman, WA 99164, USA * Corresponding author. Department of Population Medicine & Diagnostic Sciences, College of Veterinary Medicine, Cornell University, S1-088 Schurman Hall, 240 Farrier Rd., Ithaca, NY 14853, USA. Tel: +1 (607) 253-3796; E-mail: [njp27@cornell.edu](njp27@cornell.edu) Received 18 February 2026; revised version accepted 26 April 2026 . ABSTRACT Evolutionary mismatches between the reproductive life histories of women in industrialized societies and their Paleolithic ancestors are established risk factors for gynecological pathologies and breast cancer. In contemporary women, these include earlier menarche, delayed first full-term pregnancy, and reduced or absent lactation. Hormonal contraceptives lower the risks of ovarian and endometrial cancers by suppressing ovulation and modulating menstruation, and next-generation female contraceptives, including non-hormonal approaches, should aim to retain these non-contraceptive benefits. With careful design, non-hormonal contraceptives could further improve outcomes by reducing breast cancer risk, which may be variably elevated with oral contraceptive use. Importantly, these principles also have implications for male contraception, where preserving endocrine balance while achieving effective fertility control remains a central challenge. Evolutionary medicine provides a useful framework for developing contraceptives that optimize both reproductive and long-term health outcomes. Lay Summary:This commentary views the development of new female contraceptives, particularly non-hormonal contraceptives, through the lens of evolutionary medicine, which considers how the reproductive histories of present-day women in industrialized environments diverged from those of our long-ago ancestors, for whom the numbers of lifetime ovulations and menstruations were far fewer. KEYWORDS: female contraceptives; evolutionary mismatches; reproductive life histories; unopposed oestrogen effects © The Author(s) 2026 . Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. INTRODUCTION Half a century ago, Roger Short opined that ‘Since natural selection has always operated in the past to maximize reproductive potential, women are physiologically ill-adapted to spend the greater part of their reproductive lives in the non-pregnant [and non-lactating] state[s]’ [1] . Building on this insight, the risks of benign and malignant gynecological pathologies and breast cancer are heightened by the reproductive patterns that have become increasingly prevalent in industrialized societies and are markedly different from those of our evolutionary ancestors [2] . These risks are based on observations of contemporary hunter-gatherer societies, whose reproductive biology and behaviors can serve as a proxy for those of Paleolithic females, who were thought to have three-fold fewer lifetime ovulations and menstruations compared to modern-day women residing in industrialized countries owing to our ancestors’ la

FAQs

What evolutionary concept is used to frame the design of non-hormonal contraceptives for women?

The commentary links contraceptive design to evolutionary mismatches between modern reproductive life histories and those of Paleolithic ancestors, which influence gynecological disease and breast cancer risk.

Which reproductive changes in contemporary women are described as risk-related mismatches?

The text highlights earlier menarche, delayed first full-term pregnancy, and reduced or absent lactation as key elements of the mismatch.

How do hormonal contraceptives relate to cancer risks, and why does this matter for non-hormonal design?

Hormonal contraceptives lower ovarian and endometrial cancer risks by suppressing ovulation and modulating menstruation, but may variably affect breast cancer risk. Non-hormonal contraceptives should aim to retain the non-contraceptive benefits while improving long-term outcomes.

Sep 23, 2026

Uploaded by McGucket